MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.360
-0.110 (-2.46%)
May 27, 2026, 3:16 PM EDT - Market open
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $277.12 million as of May 27, 2026. Its market cap has increased by 207.23% in one year.
Market Cap
277.12M
Enterprise Value
168.30M
1-Year Change
207.23%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $277.12M, a decrease of -53.84%. That is a compound annual growth rate of -5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 284.10M | 179.08% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 306.17M |
| Opus Genetics | 304.17M |
| Eledon Pharmaceuticals | 300.71M |
| Silence Therapeutics | 292.85M |
| Niagen Bioscience | 292.11M |
| Zentalis Pharmaceuticals | 289.02M |
| Inhibikase Therapeutics | 288.01M |
| AC Immune | 280.74M |